In the latest trading session, CVS Health (CVS) closed at $59.06, marking a +1.2% move from the previous day.
Walgreens CEO Tim Wentworth is reversing his predecessors' course to focus more on retail pharmacy needs in communities compared to a more vertically integrated healthcare strategy.
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.